The 2013 BSR and BHPR guideline for the use of intravenous tocilizumab in the treatment of adult patients with rheumatoid arthritis.

Anshuman P Malaviya Jo Ledingham Jill Bloxham Aisla Bosworth Maya Buch Ernest Choy Andrew Cope John Isaacs David Marshall Gary Wright Andrew J K Ostör

Rheumatology (Oxford)

Department of Rheumatology, Broomfield Hospital, Chelmsford, Essex, Department of Rheumatology, Queen Alexandra Hospital, Portsmouth, Department of Rheumatology, Addenbrookes Hospital, Cambridge, National Rheumatoid Arthritis Society, Maidenhead, Berkshire, Academic Section of Musculoskeletal Disease, University of Leeds, Leeds, Department of Medicine, Cardiff University School of Medicine, Cardiff, Department of Rheumatology, Kings College London, London, Musculoskeletal Research Group, Newcastle University, Newcastle, Department of Rheumatology, Inverclyde Royal Hospital, Glasgow, Department of Rheumatology, Royal Victoria Hospital, Belfast and Department of Rheumatology, Addenbrookes Hospital, Cambridge, UK.

Published: July 2014

Download full-text PDF	Source
http://dx.doi.org/10.1093/rheumatology/keu168	DOI Listing

Publication Analysis

Top Keywords

2013 bsr

bsr bhpr

bhpr guideline

guideline intravenous

intravenous tocilizumab

tocilizumab treatment

treatment adult

adult patients

patients rheumatoid

rheumatoid arthritis

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!